Ralliant Corporation Declares Quarterly Dividend of $0.05 (NYSE:RAL)

Ralliant Corporation (NYSE:RAL) announced a quarterly dividend on Thursday, January 29th. Stockholders of record on Monday, March 9th will be paid a dividend of 0.05 per share on Monday, March 23rd. This represents a c) dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, March 9th.

Ralliant Price Performance

Shares of NYSE RAL traded down $1.28 during midday trading on Friday, hitting $52.58. 208,378 shares of the company’s stock were exchanged, compared to its average volume of 1,101,896. The company has a current ratio of 1.49, a quick ratio of 1.03 and a debt-to-equity ratio of 0.39. The business’s fifty day moving average price is $51.38 and its two-hundred day moving average price is $46.65. The company has a market cap of $5.93 billion and a price-to-earnings ratio of 41.47. Ralliant has a 12-month low of $40.70 and a 12-month high of $55.25.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.02. The company had revenue of $529.10 million during the quarter, compared to the consensus estimate of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.